Sanofi Capital Reinvestment Ratio
Sanofi capital reinvestment ratio. Sanofi (SNW2) has a Capital Reinvestment Ratio of 0.35x as of December 2024, meaning it reinvests 0% of its operating cash flow (€9.08 Billion) in capital expenditures (€3.19 Billion). Check Sanofi (SNW2) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sanofi (2016–2024)
Capital reinvestment ratio of Sanofi from 2016 to 2024. This chart tracks Sanofi's Capital Reinvestment Ratio across 9 annual periods. Also explore SNW2 net assets growth trend to track the company's year-over-year net asset growth rate.
Sanofi Capital Reinvestment Ratio by Year (2016–2024)
Sanofi capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see SNW2 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | €9.08 Billion | €3.19 Billion | ▲ +19.3% |
| 2023 | 0.29x | €10.26 Billion | €3.02 Billion | ▲ +93.2% |
| 2022 | 0.15x | €10.53 Billion | €1.61 Billion | ▲ +8.5% |
| 2021 | 0.14x | €10.52 Billion | €1.48 Billion | ▼ -16.9% |
| 2020 | 0.17x | €7.42 Billion | €1.25 Billion | ▼ -1.4% |
| 2019 | 0.17x | €7.71 Billion | €1.32 Billion | ▼ -32.8% |
| 2018 | 0.26x | €5.55 Billion | €1.42 Billion | ▲ +35.6% |
| 2017 | 0.19x | €7.38 Billion | €1.39 Billion | ▼ -29.2% |
| 2016 | 0.27x | €7.84 Billion | €2.08 Billion | — |